Similar articles

• THE ROLE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION.

  LEAK D. LEAK D. Geriatrics. 1965 Feb;20:150-5. Geriatrics. 1965. PMID: 14256116 No abstract available.
• [PRESENT STATUS OF ANTICOAGULANT THERAPY].

  IKEDA M, HOSODA M. IKEDA M, et al. Rinsho Naika Shonika Intern Med. 1964 Jan;19:17-34. Rinsho Naika Shonika Intern Med. 1964. PMID: 14115807 Review. Japanese. No abstract available.
• POTENTIATION OF THE EFFECT OF ORALLY ADMINISTERED ANTICOAGULANTS BY PHENYRAMIDOL HYDROCHLORIDE.

  CARTER SA. CARTER SA. N Engl J Med. 1965 Aug 19;273:423-6. doi: 10.1056/NEJM196508192730805. N Engl J Med. 1965. PMID: 14328106 No abstract available.
• LONG-TERM ANTICOAGULANT THERAPY. COMPLICATIONS AND CONTROL IN A REVIEW OF 978 CASES.

  MOSLEY DH, SCHATZ IJ, BRENEMAN GM, KEYES JW. MOSLEY DH, et al. JAMA. 1963 Dec 7;186:914-6. JAMA. 1963. PMID: 14065364 No abstract available.
• HEPARIN VERSUS ORAL ANTICOAGULANT THERAPY IN CORONARY ATHEROSCLEROSIS: REVIEW OF ADVANTAGES AND DISADVANTAGES.

  HUGHES ML Jr, MORTENSEN F, SHOURIE L. HUGHES ML Jr, et al. South Med J. 1964 Mar;57:292-6. doi: 10.1097/00007611-196403000-00012. South Med J. 1964. PMID: 14128542 Review. No abstract available.